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Abstract In a previous study, a biological response modifier
(BRM) specifically enhancing the function of B-cells was
isolated from Korean fermented soybean paste (Kfsp),
but not from non-fermented soybeans. In this study, we
attempted to isolate the bacteria producing the BRM from
Kfsp (KfspBRM) by ELISA using anti-KfspBRM and by
B-cell proliferation. Five bacteria whose culture supernatants
showed the BRM activities were isolated, and one of them
was identified as Bacillus licheniformis E1. The bacterial
BRM (bBRM) originated from a slime layer of B. licheniformis
E1 had a molecular weight of 1,594 kDa, and contained 33%
(w/w) of reduced sugar and 4.6% (w/w) of protein content.
The bBRM appeared to be a glycoprotein that is physically,
structurally, and functionally similar to the KfspBRM, suggesting
that the isolates including B. licheniformis E1 may produce
the KfspBRM in the fermentation process of soybean paste.
The mass production of the BRM by the bacterium may help
to study B-cells in immunology, and the enrichment of the
BRM in Kfsp may help patients in future who are medically
in need of potentiation of B-cell proliferation and antibody
production.
Key words: Bacillus licheniformis, biological response
modifier (BRM), B-cell-specific BRM
Several classes of compounds including proteins, peptides,
lipopolysaccharides, glycoproteins, and lipid derivatives
are recently being known as BRMs that upregulate or
downregulate the host immune system [32]. Certain
polysaccharides, produced by microorganisms that were
introduced by researchers, act as potent BRMs. Most of
the polymers show specific activity for both T-cells
and antigen-presenting cells (APCs) such as monocytes
and macrophages, but not for B-cells [32]. One Kfsp,
Doenjang, is a traditional food produced through the
fermentation of soybeans by bacteria and fungi in nature,
and has been consumed for centuries as a protein source and
flavoring [19]. In the investigation of the functionality of
foods, Kfsp has been shown to contain various biologically
active substances, including antitumor [1, 16], antithrombosis
[26], antioxidants, and hydrophilic brown pigment [3, 4].
Recently, we isolated BRM from Kfsp and found that the
BRM induces the proliferation of B-cells, but not T-cells,
and that it enhances the antibody production of B-cells.
The BRM was detected only in fermented soybean paste
and not in non-fermented soybean paste [19], suggesting
that microorganisms involved in the fermentation process
of soybean paste might produce the BRM.
In this study, we attempted to isolate the KfspBRM-
producing bacteria from the Kfsp, and investigated the
characteristics of the BRM produced by the isolate.
MATERIALS AND METHODS
Animals
BALB/c female mice between 6 and 7 weeks of age and
female rabbits (2.5 kg/rabbit) were purchased from the
Korean Advanced Institute of Science and Technology
(Daejeon, Korea) and Samtaco Animal Farm (Osan, Korea),
respectively. The animals were maintained and used in
accordance with the guidelines prepared by the Yonsei
University College of Medicine (Seoul, Korea), which has
been fully accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care, International
(AAALAC), for the care and use of laboratory animals.
Isolation of Bacteria from Kfsp
Kfsp was obtained from Sunnchang Traditional Foods Co.
(Sunchang, Korea). Ten g of samples were harvested from
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the top, middle, and bottom of the jar containing the
Kfsp, and then pooled. One g of the pooled sample was
suspended in 10 ml of saline. One ml of the suspension
was harvested and spun down at room temperature (RT)
and 10,000 ×g for 10 min using a microfuge (Type; A-14,
Jouan, Milan, Italy). The supernatant was discarded, and
the sediment was suspended in 1 ml of saline. The suspension
was diluted at various concentrations with saline, inoculated
on brain heart infusion (BHI: Difco, Becton Dickinson and
Company, Sparks, MA, U.S.A.) agar plates supplemented
with 5% of NaCl, and cultured at 37
o
C for 2 to 5 d under
aerobic or anaerobic conditions. The isolation of the bacteria
was based on the morphology of the colony and Gram staining.
Screening of KfspBRM-Producing Bacteria
The isolates obtained from Kfsp were inoculated in 20 ml
of BHI broth in 50-ml plastic tubes and cultured by
shaking at 37
o
C under aerobic and anaerobic conditions.
Their incubation periods were 2 d for aerobes and 5 d for
anaerobes. The cultured fluids were boiled and then spun
down at 4
o
C at 10,000 ×g for 1 h using a Sorvall centrifuge
(Type; ss-34, Thermo Electron Corporation, Asheville, NC,
U.S.A.). Ten ml of the supernatant was concentrated to
1 ml by using DIAFLO Centricon Plus-80 (Amicon, Inc.,
Bedford, MA, U.S.A.). The concentrate (100 µl) obtained
from each of the isolates was mixed with 200 µl of
carbonate-bicarbonate coating buffer, and the mixture
(100 µl/well) was coated on a 96-well ELISA plate (Nunc,
Copen-hagen, Denmark) at 4
o
C for 24 h. The plates were
washed three times with phosphate-buffered saline containing
0.05% Tween 20 (PBST) and blocked with 150 µl/well
of PBS containing 10% bovine serum albumin (Sigma-
Aldrich, Steinheim, Germany) for 2 h at RT. The primary
antibody used was anti-KfspBRM prepared in the previous
study from rabbits immunized with KfspBRM [19], and
the secondary antibody was peroxidase-conjugated goat
anti-rabbit immunoglobulin (PharMingen, San Diego, CA,
U.S.A.). The reaction products were read with an ELISA
plate reader at 450 nm.
Preparation of T-Cells and B-Cells
T-cells and B-cells were obtained from the lymphocytes of
mouse spleen. A single cell suspension of lymphocytes
was prepared by gently teasing the spleen between two
glass slides. Then, the contaminated red blood cells were
lysed using an ammonium-chloride-potassium lysing buffer
[17]. The cells (2×10
7
cells/ml) were suspended in RPMI
1640 medium supplemented with 10% heat-inactivated fetal
calf serum (FCS), 2 mM L-glutamine, 2.2 mM sodium
bicarbonate, 100 U/ml penicillin, and 100 µg/ml streptomycin
(GIBCO BRL, Grand Island, NY, U.S.A.) (hereafter, referred
to as the complete medium). To discard adherent cells, the
cells were cultured in 75 cm
2
 plastic culture flasks (Corning
Inc., NY, U.S.A.) for 3 h at 37
o
C in a humidified 5% CO
2
incubator (hereafter referred to as the incubator). Nonadherent
cells were harvested by gently shaking the culture flasks.
T-cells and B-cells from nonadherent cells were isolated
by negative selection with Dynabeads mouse pan B (B
220) and pan T (Thy1.2) (Dynal AS, Oslo, Norway),
respectively, according to the manufacturer’s direction.
Assay for B-Cell-Specific BRM
The activity of BRM produced by bacteria was measured
by the proliferation of B-cells. The fractionated B-cells in a
complete medium (2.5×10
5
cells/well) were plated in 96-
well round bottomed microtiter plates (Corning). Fifty ml
of the bacterial culture fluids or the purified bBRM was
added to each well, and the plates were cultured in an
incubator for 48 h. The cell proliferation was measured
using the technique of 6 h 
3
H-tymidine (
3
H-TdR, New
England Nuclear, Boston, MA, U.S.A.) incorporation.
Identification of Bacteria
The isolate that showed a high level of BRM activity was
identified by Bergey’s Manual of Systematic Bacteriology
[28], based on general characteristics, and by sequencing
the 16S DNA gene. For biochemical testing, the isolate
was cultured in a nutrient broth at 30
o
C for 24 h. After
cultivation, the cultured suspension was inoculated in
an API 50 CHB kit (bioMerieux Co., Marcy 1’Etoile,
France), incubated at 30
o
C for 24 or 48 h, and identified
by using the API 50 CHB database v. 3.0. The gene
sequencing of the 16S rDNA of the isolate was performed
by PCR technique. To amplify a partial 16S rDNA fragment
of the isolate, universal primers (27F:5'-AGAGTTTGAT-
CATGGCTCAG-3' and 1492R:5'-GGATACCTTGTTAC-
GACTT-3') were used. The amplified PCR product was
ligated into a T vector (Invitrogen Co., Seoul, Korea), and
DNA sequencing was performed using an ABI 377
Genetic Analyzer (PE Applied Biosystems, Foster City,
CA, U.S.A.). The 16S rDNA sequence was then aligned
with reference sequences obtained from the GenBank
databases (NCBI, Bethesda, MD), using the Blast searches
(http://www.ncbi.nlm.nih.gov).
Purification of Bacterial BRM
Purification of BRM from the bacterial culture fluid was
performed by the method used for isolation of KfspBRM
in the previous study [19]. Briefly, the isolate E1 producing
BRM was cultured in BHI broth on a shaker at 37
o
C
for 2 d. The cultured fluid was spun down at 10,000 ×g
at 4
o
C for 1 h. The harvested supernatant was boiled at
100
o
C for 30 min and spun down again in the same way as
above. The supernatant was concentrated using a DIAFLO
ultrafiltration membrane (Filter code: YM 100, Millipore
Corporation, Bedford, MA, U.S.A.). Five ml of the concentrate
was applied to a column (25×330 mm) of DEAE Sepharose
Fast Flow (Pharmacia, Biotech, AB Uppsala, Sweden)
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previously equilibrated with 0.05 M phosphate buffer (pH
7.4), and the column was eluted with a linear gradient of
0.0-1.0 M NaCl in the phosphate buffer at a flow rate
of 2 ml/min. Five ml of the fractions was collected, and
monitored at 280 nm, and their BRM activities measured by
mouse B-cell proliferation assay. Those elutes showing
bBRM activity were pooled and concentrated using the
same ultrafiltration membrane. One ml of the concentrate
was subjected to a column (16×900 mm) of Sephacryl S-
500 (Amersham Biosciences, Uppsala, Sweden) previously
equilibrated with the phosphate buffer and eluted with the
same buffer at a flow rate of 1 ml/min. Three ml of each
fraction was collected and monitored at 280 nm. Those
eluates rich in bBRM were pooled and concentrated by the
same ultrafiltration membrane. The concentrate was again
subjected to a Superose TM 6HR column (Amersham
Biosciences), and the fractions were monitored at 214 nm.
The fractions at the peak of bBRM activity were collected,
pooled, concentrated, and freeze-dried (the BRM produced
by the isolate E1 is hereafter referred to as bBRM).
Molecular Weight Analysis
The molecular weight of bBRM was estimated by the gel
permeation chromatography (GPC) system with a column
of ultrahydrogel 250 (7.8×300 mm), ultrahydrogel 500 (7.8×
300 mm), and ultrahydrogel 1000 (7.8×300 mm), using a
conventional HPLC system with a refractive index detector.
The columns were eluted with distilled water at a flow rate
of 1 ml/min. Calibration of the columns was performed
using several kinds of dextrans (molecular weights of 10-
2,000
 
kDa; Sigma-Aldrich).
Carbohydrate Analysis
The total carbohydrate content was quantified by the
method of Dubois et al. [7]. The bBRM (75 µl) was mixed
with 5% phenol reagent (75 µl), and 375 µl of H
2
SO
4
 was
also added to the solution. The mixed solution was allowed
to stand in an ice bath for 5 min and reacted at 80
o
C for
30 min, and the total carbohydrate content was measured
by a spectrophotometer at 492 nm. Galactose (G-6404,
Sigma-Aldrich) was used as a standard. Sugar composition
of the bBRM was analyzed by a modified method of Park
and Yun [24]. Briefly, the bBRM was hydrolyzed with 2 M
trifluoroacetic acid (TFA) for the neutral sugar and 6 N
HCl for the amino sugar at 100
o
C. A Dionex CarboPac
PA column (4.5×250 mm) was used, and the hydrolyzates
were analyzed using Bio-LC DX-600 (Dionex, Sunnyvale,
CA, U.S.A.) with an electrochemical detector (Dionex ED50).
The column was eluted with 16 mM sodium hydroxide at a
flow rate of 1 ml/min.
Protein Analysis
The total protein content of bBRM was determined by the
method of Ohnishi and Barr [22]. The bBRM (50 µl) was
added to 550 µl of Biuret reagent (Sigma-Aldrich) and
allowed to stand at RT for 10 min. This solution was mixed
with 25 µl of Folin and Ciocalteu’s phenol reagents (Sigma-
Aldrich) and allowed to stand at RT for 30 min. The protein
content of bBRM was estimated by spectrophotometery
at 752 nm, and bovine serum albumin (Sigma-Aldrich)
was used as a standard protein. The amino acid composition
of bBRM was carried out by the Pico-Tag method [29].
After hydrolysis with HCl at 110
o
C for 24 h, derivatization
of the hydrolyzed bBRM was accomplished using the
derivatizing solution [ethanol/distilled water/triethylamine/
phenylisothiocyanate (PITC), 7/1/1/1, v/v] for 15 min. PITC-
derivatized amino acids were applied to a Pico-Tag column
(3.9×300 mm, Waters, Milford, MA, U.S.A.) equilibrated
with 140 mM sodium acetate and equipped with a Waters
HPLC system. The column was eluted with a linear
gradient of 0-60% acetonitrile in 140 mM sodium acetate
at a flow rate of 1 ml/min at 46
o
C.
FT-IR Spectrum Analysis
The bBRM was hydrolyzed with 2 M HCl for 5 h at 100
o
C.
The infrared spectrum of the hydrolyzate was measured using
a Fourier transform infrared (FT-IR) spectrophotometer
(Perkin-Elmer, Inc. Boston, MA, U.S.A.) with Miracle
TM
attenuated total reflectance (ATR).
Antibody to bBRM
The bBRM was used as antigen. A rabbit was immunized
subcutaneously (s.c.) with a mixture of the bBRM and
complete (first week) or incomplete (the rest of 3 weeks)
Freund’s adjuvant (Sigma-Aldrich) once a week for 4
weeks. The antibody from the rabbit was referred to as
anti-bBRM and stored at -20
o
C.
Adherence of Anti-bBRM or Anti-KfspBRM to a
Bacterial Slime Layer
B. licheniformis E1 was cultured in BHI broth for 24 h and
washed 3 times with saline. The bacterium was treated
with 10% formaldehyde for 1 h, washed 3 times with
saline, and reacted with either anti-bBRM, anti-KfspBRM,
or control rabbit serum. After washing with saline, the
bacteria were stained with FITC-conjugated goat anti-
rabbit immunoglobulin (PharMingen) and analyzed using
a FACScan flow cytometer (Becton Dickinson, San Jose,
LA, U.S.A.) or captured using a confocal microscope with
COMPIX software (Carl Zeiss, Oberkochen, Germany).
Adherence of bBRM to Lymphocytes
The fractionated T-cells or B-cells (1×10
6
cells/ml) from a
normal mouse were treated with 2 µg of bBRM or saline
at 37
o
C for 1 h. After washing with phosphate-buffered
saline, the cells were reacted with anti-bBRM at 4
o
C for
30 min, washed with PBS, and then stained with FITC-
conjugated goat anti-rabbit immunoglobulin at 4
o
C for 30 min.
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The cells were captured using a confocal microscope with
COMPIX software.
Statistical Analysis
All data were expressed as mean±SD of three independent
experiments (n=3). The differences were analyzed using
the Student’s t-test, but the statistics did not show when the
standard deviation divided by the mean was small and the
difference between groups was large.
RESULTS
Isolation of Bacteria from Kfsp
In order to isolate bacteria growing in the fermentation
process of soybean paste, samples harvested from several
areas of a jar containing Kfsp were inoculated on BHI agar
plate supplemented with 5% NaCl (as Kfsp usually contains
5% or more of NaCl) and incubated at 37
o
C for 2 to 5 d
under either aerobic or anaerobic conditions. The bacteria
cultured were preliminarily identified on the basis of their
colony and cellular morphology. As shown in Table 1, a
total of 31 kinds of bacteria were isolated from Kfsp
fermented for 1 year. Among the isolates, there were 25
kinds of aerobic bacteria and 6 kinds of anaerobic bacteria.
Aerobic isolates included 20 kinds of Gram-positive (Gram
+
)
bacteria (12 rod and 8 coccus forms) and 5 kinds of Gram-
negative (Gram
-
) ones (3 rod and 2 coccus forms), whereas
anaerobic isolates appeared to include 4 kinds of Gram
+
bacteria (3 rod and 1 coccus forms) and 2 kinds of Gram
-
cocci.
Selection of Bacteria that Produce Substance Reactive
with Anti-KfspBRM
Among 31 isolates, only 24 kinds of Gram-positive bacteria
were cultured in BHI broth under aerobic or anaerobic
conditions, and their culture fluids were boiled at 100
o
C
for 30 min. The serological responses of the concentrates
from the bacterial culture fluids to anti-KfspBRM that
were obtained from a rabbit immunized with KfspBRM
were examined using the ELISA method. The concentrates
from the bacterial culture fluids obtained from each of the
9 isolates (A2, B1, B4, C1, C3, C5, D1, E1, and E2) of
aerobic Gram-positive bacilli strongly reacted with anti-
KfspBRM. Their reactions were more than 0.5 of optical
density (O.D.). In contrast, those from the rest of the
isolates (13 strains) showed low levels of O.D. (below 0.1)
in the reaction with the antibody (data not shown).
The Biological Effect of the Bacterial Culture
Concentrates, Reactive with Anti-KfspBRM, on the
Proliferation of T-Cells or B-Cells
It was assessed that the concentrated culture fluids obtained
from each of the 9 isolates strongly reacted with anti-
KfspBRM. Therefore, to find out whether the concentrates
would share the same biological function with KfspBRM,
the effect of the concentrated culture fluid on the proliferation
of B-cells and T-cells was examined by 6 h-
3
H-TdR
incorporations. As shown in Fig. 1, high levels of 
3
H-TdR
incorporation by B-cells were shown in groups treated
with the concentrated culture fluids from each of the 5
isolates: A2 (9.92±1.58 kcpm), B4 (8.62±0.67 kcpm), C5
(6.5±0.68 kcpm), E1 (16.7±2.08 kcpm), and E2 (12.22±
2.08 kcpm). In contrast, those from groups treated with the
concentrated culture fluids from each of the rest of the 4
isolates (B1, C1, C3, and D1) were below 1.0 kcpm, and
were similar to that of B-cell treated with the medium as
control. On the other hand, none of the enhanced proliferation
of T-cells was found in groups treated with the concentrated
culture fluids from the 9 isolates, and their 
3
H-TdR
incorporation was below 1.0 kcpm, which was similar to
that of T-cells treated with the medium. Even if the
Table 1. Isolation of bacteria from Kfsp
a
 fermented for 1 year in
nature environment.
Group
Number of isolates
b
 obtained from Kfsp
Gram-positive Gram-negative
Rod Coccus Rod Coccus
Aerobes 12 8 3 2
Anaerobes 03 1 2
a
Samples were harvested from the top, middle, and bottom of the jar that
contained Kfsp.
b
Isolation of bacteria was based on the morphology of colony and Gram’s
staining.
Fig. 1. The proliferative responses of T-cells or B-cells treated
with the concentrates from the bacterial culture fluids that reacted
with anti-KfspBRM.
T-cells and B-cells fractionated from mouse spleen were distributed into
96-well round-bottomed microtiter plates. Fifty µl of 5-fold diluted
concentrates from each of the bacterial culture fluids was added to the
wells, and the mixtures were incubated for 48 h. The cell proliferation was
measured using the technique of 6 h 
3
H-TdR incorporation. Each value
represents mean±SD of three independent experiments (n=3).
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concentrated culture fluids from each of the 9 isolates
showed the serologic responses to anti-KfspBRM in the
ELISA test as shown above, their biologic responses to
induce the proliferation of B-cells were found only in those
from each of the 5 isolates, suggesting that the 5 isolates
produce bBRM specific for B-cells, but not for T-cells.
Identification of the Isolate Producing BRM Specific
for B-cells
For further study of the bacterial BRM, we selected
the isolate E1 that induced the highest level of 
3
H-TdR
incorporation by B-cells, and performed the identification
of the isolate. For macro- and microscopic examinations,
the E1 isolate was grown in aerobic conditions and found
to be Gram-positive spore-forming rod. In the biochemical
test using API 50 CHB, the E1 isolate utilized 99.9% of
carbohydrates used by B. licheniformis (data not shown).
When the 16S rDNA gene sequence of the E1 isolate was
compared with that of GenBank using the BlastN program,
the E1 isolate appeared to be closely connected with B.
licheniformis, as shown in the phylogenetic tree (Fig. 2).
These results suggest that the isolate is B. licheniformis.
Therefore, we referred to the E1 isolate as B. licheniformis
E1.
bBRM Activities of the Excreta and the Slime Layer of
B. licheniformis E1
To investigate whether the bBRM originated from the
excreta or from the slime layer of B. licheniformis E1,
the B. licheniformis E1 was cultured in 3 l of BHI broth
for 48 h, spun down, and divided into two groups, A
and B: Group A was a mass of bacteria (5.4 g of wet
weight) and group B was a culture fluid (3 l). Group A
was suspended in 100 ml of saline, heated for release of
water-soluble slime layer from the bacterium at 100
o
C for
30 min, and spun down. Group B was also heated at 100
o
C
for 30 min and spun down. The supernatant harvested
from each of the groups was concentrated to 50 ml by
using a DIAFLO ultrafiltration membrane (Filter code:
YM 100). Figure 3 shows the bBRM activities of the
concentrates from groups A and B, estimated by proliferation
of B-cells. B-cells treated with the diluted concentrates
obtained from group B showed marked proliferative
responses, and their 
3
H-TdR incorporations at 1/40, 1/160,
and 1/640 diluted concentrates were 16.46±0.72, 12.32±
0.64, and 8.24±0.62 kcpm, respectively. In contrast, the
proliferation of B-cells treated with the diluted concentrates
from group A appeared to be low, compared with those of
B-cells treated with group B, and their 
3
H-TdR incorporation
at 1/40, 1/160, and 1/640 diluted concentrates were 5.3±
0.52, 3.45±0.51, and 2.05±0.39 kcpm, respectively, but
were significant compared with that of B-cells treated with
medium as control. This means that both groups increased
the proliferation of B-cells, suggesting that the bBRM might
have originated from the slime layer of B. licheniformis
E1.
The Specific Binding of Anti-bBRM and Anti-KfspBRM
to the Slime Layer of B. licheniformis E1
To further clarify that the origin of bBRM or KfspBRM was
the slime layer of the bacteria, B. licheniformis E1 cultured
in a BHI broth for 24 h was reacted with rabbit anti-bBRM,
rabbit anti-KfspBRM, or control rabbit serum, stained with
FITC-conjugated goat anti-rabbit immunoglobulin, and
Fig. 2. The phylogenetic tree of the E1 isolate based on homology
of the 16S rDNA gene sequence.
A 16S rDNA gene sequencing of the isolate was performed by PCR. The
universal primers used for amplification of a partial 16S rDNA fragment of
the isolate were 27F:5'-AGAGTTTGATCATGGCTCAG-3' and 1492R:5'-
GGATACCTTG TTACGACTT-3'. They were ligated into a T vector, and
their products were sequenced using an ABI 377 Genetic Analyzer. The
16S rDNA sequence was then aligned with reference sequences obtained
from the GenBank databases, using the Blast searches.
Fig. 3. BRM activity of a slime layer and a culture fluid obtained
from B. licheniformis E1.
B-cells fractionated from mouse spleen were distributed into 96-well round-
bottomed microtiter plates. Fifty µl of either the diluted concentrates from
the culture fluid or the diluted concentrates from the slime layer were
added to the wells, and they were incubated for 48 h. The cell proliferation
was measured using the technique of 6 h 
3
H-TdR incorporation. Each value
represents the mean±SD of three independent experiments (n=3).
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analyzed by FACScan flow cytometry. As shown in Figs. 4A-
4C, B. licheniformis E1 showing specific immunofluorescence
increased in groups treated with anti-bBRM (62.05%)
and anti-KfspBRM (35.01%), but not in those treated
with control rabbit serum (1.98%), observed by confocal
microscopy. B. licheniformis E1 treated with anti-bBRM
or anti-KfspBRM showed specific immunofluorescence and
the bacteria were agglutinated. In contrast, those treated with
the control rabbit serum showed neither immunofluorescence
nor the antibody-mediated aggregations (data not shown).
The results indicate that both anti-bBRM and anti-
KfspBRM bind to the slime layer of B. licheniformis E1,
suggesting that the origin of bBRM is a slime layer of B.
licheniformis E1 and that KfspBRM might also originate
from B. licheniformis E1.
Purification of bBRM from B. licheniformis E1 and its
Molecular Weight
For a mass production of the bBRM, B. licheniformis
E1 was cultured in BHI broth on a shaker for 48 h. Since
the bBRM is heat-stable, the supernatant harvested from
the bacterial culture was boiled in order to denature
contaminated proteins. Purification of the bBRM from
the supernatant was performed by the same method as
that used to purify the KfspBRM from the Kfsp in the
previous study [19]. Measurement of molecular weight of
the purified bBRM was performed by the GPC system,
and various molecular weights of dextrans were used for
calibration of the column. As shown in Fig. 5, the bBRM
appeared to be highly polymerized, having a molecular
weight of 1,594 kDa.
Chemical Composition of bBRM
Carbohydrates and proteins of bBRM were analyzed, and
their contents were calculated in terms of percentages.
The bBRM contained 33% (w/w) of reduced sugar (data
not shown), and its sugars included glucosamine (35.1%),
galactose (34.8%), galactosamine (22.6%), and glucose
(7.5%) (Table 2). On the other hand, the protein content
of the bBRM was shown to be 4.6% (w/w) (data not
shown), and its major amino acids included serine (17.2%),
proline (11.7%), tryptophan (11.5%), and alanine (10.1%)
(Table 3).
Fig. 4. The specific immunofluorescence of B. licheniformis E1 to anti-bBRM or anti-KfspBRM.
B. licheniformis E1 cultured for 24 h was reacted with anti-bBRM, anti-KfspBRM, or control rabbit serum, and stained with FITC-conjugated goat anti-
rabbit immunoglobulin. The stained bacteria were analyzed by FACScan flow cytometry (A, B, and C).
Fig. 5. Molecular weight of bBRM. The molecular weight of
the bBRM was estimated by the GPC system with a column of
ultrahydrogel 250, ultrahydrogel 500, and ultrahydrogel 1000.
The running sample was eluted with distilled water. Calibration of the
columns was performed using dextrans (10-2,000 kDa) as reference
molecular weight markers.
Table 2. Sugar composition of bBRM.
Sugar pmol mol %
Galactosamine 0,255 022.6
Glucosamine 0,396 035.1
Galactose 0,392 034.8
Glucose 0,084 007.5
Total 1,127 100.0
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FT-IR Spectrum of bBRM
To further obtain molecular information, the bBRM was
analyzed using FT-IR. As shown in Fig. 6, the FT-IR
spectrum of the bBRM showed an absorption peak at
3,280 cm
-1
, representing a typical OH stretching from a
bound sugar group. The peak at 2,925 cm
-1
 is characteristic
of absorption by the methyl group, and that at 1,737 cm
-1
 is
a typical spectrum of uronic acid. The absorption peaking
at 1,581 cm
-1 
and 1,414 cm
-1
 indicate amide and carboxyl
groups, respectively. This means that the bBRM includes
protein. Therefore, the bBRM might be a glycoprotein.
Adherence of bBRM to T-Cells and B-Cells
The specific binding of bBRM to T-cells or B-cells was
examined. Thus, the fractionated T-cells or B-cells treated
with the bBRM or saline at 37
o
C for 1 h was reacted with
anti-bBRM. After washing, the cells were stained with FITC-
conjugated goat anti-rabbit immunoglobulin and then
observed by confocal microscopy. As shown in Fig. 7, the
specific immunofluorescence was detected on both T-cells
and B-cells treated with anti-bBRM, but not on those
treated with saline, and the bBRM-treated cells showed a
tendency to aggregate with each other, compared with the
saline-treated cells. This means that the bBRM binds to
both B- cells and T-cells, thereby aggregating the cells.
DISCUSSION
We isolated 5 kinds of bacteria producing B-cell-specific
BRM from Kfsp, and found that physical and biological
characteristics of the bBRM produced by one of the
isolates were similar to those of KfspBRM. In a previous
study, we reported that the BRM specific for B-cell is
found in Kfsp, and suggested that bacteria involved in
fermentation of Kfsp may produce the BRM, because it
was found only in the fermented soybean paste, but not in
Table 3. Amino acid composition of bBRM.
Amino acid pmol mol %
Cys 388 4.6
Asp
a
625 7.5
Glu
b
487 5.8
Ser 1,431 17.2
Gly 502 6.0
His 199 2.4
Arg 89 1.1
Thr 438 5.3
Ala 838 10.1
Pro 979 11.7
Tyr 406 4.9
Val 168 2.0
Met 209 2.5
Cys2
c
50 0.6
Ile 178 2.1
Leu 209 2.5
Phe 83 1.0
Trp 955 11.5
Lys 100 1.2
Total 8,336 100.0
a
Asp, amount of aspartate and asparagines.
b
Glu, amount of glutamate and glutamine.
c
Cys2, disulfide-linked cysteine.
Fig. 6. Infrared absorption spectrum of bBRM. OH group of sugar,
3,280 cm
-1
; methyl group, 2,925 cm
-1
; uronic acid, 1,737 cm
-1
;
amide group, 1,581 cm
-1
; carboxyl group, 1,414 cm
-1
; ester group,
1,217 cm
-1
.
Fig. 7. Binding of bBRM to T-cells and B-cells.
T-cells or B-cells fractionated from mouse spleen were treated with the
bBRM or saline at 37
o
C for 1 h. The cells were reacted with anti-bBRM,
and then stained with FITC-conjugated goat anti-rabbit immunoglobulin.
The cells were observed by confocal microscopy.
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the non-fermented soybean paste. Therefore, we attempted
to isolate bacteria from Kfsp that produce the BRM.
First of all, the bacteria in Kfsp were isolated, and a total
of 31 kinds of bacteria including aerobes and anaerobes
were isolated. In this experiment, the culture medium used
was a BHI agar plate supplemented with 5% NaCl, since
the concentration of NaCl in Kfsp is generally more than
5%. Therefore, the isolates are considered to be halophilic
bacteria.
Since the cell envelope of Gram-negative bacteria contains
lipopolysaccaride (LPS) that functions as B-cell mitogen
[11, 20], Gram-positive bacteria of the isolates were selected
by screening bacteria producing KfspBRM. The concentrates
from the culture fluids of Gram-positive bacteria were heated
to denature various proteins contaminated. This was possible
because KfspBRM is heat stable, and their responses to
anti-KfspBRM were measured by the ELISA method. In
this experiment, we found that the concentrated culture
fluids obtained from each of the 9 isolates strongly reacted
with anti-KfspBRM. When the 9 concentrates were added
to T-cells, no excess proliferation occurred. However, when
they were added to B-cells, the enhanced proliferation of
B-cells was observed in 5 of the 9 isolates. These results
indicate that 5 kinds of bacteria isolated from Kfsp produce
a B-cell-specific BRM shown in KfspBRM, because the
concentrated culture fluids from those 5 kinds induced the
proliferation of B-cells and their biological activities were
heat stable.
Macro- and microscopic examinations revealed that the
5 isolates producing BRM specific for B-cells are aerobic
Gram-positive spore-forming rods. Since the E1 isolate of
the 5 isolates strongly increased the proliferation of B-cells,
the isolate was selected for study of the characteristics of
bBRM. The E1 isolate was identified as B. licheniformis
and referred to B. licheniformis E1.
The examination of the origin of bBRM showed that
both the concentrated culture fluid and the concentrated
water-soluble slime layer of B. licheniformis E1 induced the
proliferation of B-cells. However, the degree of proliferation
was significantly higher in cells treated with the concentrated
culture fluid than those treated with the concentrated water-
soluble slime layer. These results suggest that bBRM
originated from the slime layer of the bacteria. The reason
why the activity of bBRM was higher in the concentrated
culture fluid than in the concentrated water-soluble slime
layer might be accumulation of bBRM released from the
slime layer of the bacterium during cultivation.
To further confirm the fact that the origin of bBRM
was a slime layer of the bacteria, the specific binding
of anti-bBRM and anti-KfspBRM to the slime layer of
B. licheniformis E1 was examined by immunofluorescent
analysis. The result showed that specific immunofluorescence
observed by FACScan flow cytometry and confocal microscopy
was detected only in B. licheniformis E1 treated with anti-
bBRM and anti-KfspBRM, but was not detected in the
control rabbit serum. This confirms the above notion that
bBRM originates from the slime layer of B. licheniformis E1,
suggesting that KfspBRM may also originate from the
slime layer of the 5 kinds of aerobic Gram-positive spore-
forming bacilli that induced the proliferation of B-cells
(Fig. 1).
bBRM was purified from the cultured fluid of B.
licheniformis E1 by the same method used for that of
KfspBRM from Kfsp in the previous study [19]. The
molecular weight of the bBRM (1,594 kDa) differed only
slightly from that of KfspBRM. The small difference between
their molecular weights may be due to environment and
different bacteria, including B. licheniformis, producing
the BRMs. The difference may also be attributed to the
fact that the bBRM and the KfspBRM were isolated from
BHI broth cultured with B. licheniformis E1 and from the
soybean paste fermented with many kinds of bacteria,
respectively.
Chemical analysis showed that the bBRM contained
33% of reduced sugar and 7.5% of protein content, however,
we did not determine the makeup of the remaining 59.5%.
Accordingly, further analysis of the remaining parts of the
bBRM will be needed in future. The sugar components
of the bBRM appeared to be glucosamine, galactose,
galactosamine, and glucose, and its major protein components
were serine, proline, tryptophan, and alanine.
Further investigations, using FT-IR, revealed that the
bBRM has a typical peak of OH stretching from the bound
sugar group. The bBRM also showed peaks to indicate
amide and carboxyl groups as well as acid sugar (uronic
acid). The above results indicate that the bBRM contains
not only neutral, acid, and amino sugars, but also includes
proteins, suggesting that the bBRM is a glycoprotein.
Recently, it has been reported that microbial polysaccharides
also show BRM activity [32]. Polysaccharide A (PS A)
isolated from Bacteriodes fragilis induces abscess formation in
animals, but also acts an as immunomodulator with activity
specific for T-cells [22, 25]. β (1-3)-Glucan, glucose polymer,
purified from fungi was reported to enhance macrophage
phagocytosis [12, 13, 34] and to increase in the proportion
of neutrophils and eosinophils [5, 33]. Mushrooms are
also known to produce protein-bound polysaccharides that
stimulated T-cell activation [21]. Furthermore, streptococci
produce hyaluronic acid, which is a major carbohydrate
component of the extracellular matrix of mammalian tissue,
and has been shown to activate T-cell [27]. Most BRMs
are shown to be specific for T-cells, neutrophils, and
eosinophils, whereas only a few polymers are reported to
be BRM specific for B-cells. These include proteoglycan
isolated from Phellinus linteus, and polysaccharide from
Acanthopanax senticosus [9, 14, 15].
In the present study, we demonstrated that bBRM, the
product of B. licheniformis E1 and KfspBRM, functions as
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a potent B-cell-specific BRM. The physiological and
biochemical characteristics of γ-polyglutamic acid (PGA)
produced by B. licheniformis 9945a have been reported
[2]. It is an unusual naturally occurring anionic, water-
soluble polyamide, synthesized as a bacterial slime layer
by several Bacillus species including B. licheniformis
9945a [8, 10, 18, 30, 31]. Although both bBRM and PGA
are protein-containing polymers originated from the slime
layer of B. licheniformis, the sugar and amino acid
components of the bBRM are different from those of PGA,
and their biological functions are also different from each
other.
To clearly prove that the bBRM is specific for B-cells
but not T-cells, adherence of the bBRM to T-cells and B-
cells was examined by confocal microscopy. The results
showed that specific immunofluorescence was found not
only on the surface of B-cells, but also on the surface of T-
cells treated with bBRM, and that the aggregation of the
cells occurred in groups treated with the bBRM, but not in
groups treated with saline. These results indicate that the
bBRM binds to both T-cells and B-cells, thereby inducing
the aggregation of the cells. However, as shown in Fig. 1,
the proliferation by the bBRM occurred only in B-cells and
not in T-cells. This suggests that, although both T-cells and
B-cells have receptors specific for bBRM, the receptor-
mediated signal for activation of cells is induced only in B-
cells [6].
In conclusion, we isolated BRM-producing B. licheniformis
E1 from Kfsp, and found that the bBRM is a novel
polymer inducing B-cell-specific proliferation, and that it
originates from the slime layer of the bacteria. The bBRM
reacted serologically with anti-KfspBRM, and its physical
and biological characteristics were also found to be similar
to those of KfspBRM.
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